Achondroplasia (ACH) is a skeletal dysplasia characterized by disproportionate short stature, resulting from the constitutive activation of fibroblast growth factor receptor 3 (FGFR3), with an estimated global prevalence of over 250,000 individuals [1,2]. Here, FGFR3 is linked to skeletal dysplasia.